CD33 CAR T-cell
3 abstracts
Abstract
Phase I study of functionally enhanced CD33 CAR T cells in patients with relapsed or refractory acute myeloid leukemia.Org: Beijing Boren Hospital, Beijing GoBroad Boren Hospital, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Blood Diseases Hospital,
Abstract
Presence of CD8+ cytotoxic T-cells in proximity to tumor cells, TIM3, CTLA-4 and prognostic implications for muscle-invasive urothelial cancer.Org: University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Charité Berlin, Berlin, Germany, Charité Universitätsmedizin Berlin,
Abstract
Precision immuno-oncology (IO) ISH/IF multiplex panel: Spatial detection of cytokines and IO biomarkers.Org: Lanterne Dx, Boulder, CO, Compugen,